Halis Akturk, MD

Professional Titles

• Associate Professor of Medicine

Research Interests

Publications

• Polsky S, Akturk HK. Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes. Curr Diab Rep. 2017 Nov 4;17(12):136. PubMed PMID: 29103170
• Garg SK, Akturk HK. The Future of Continuous Glucose Monitoring. Diabetes Technol Ther. 2017 Jun;19(S3):S1-S2. PubMed PMID: 28585872
• Garg SK, Shah VN, Akturk HK, Beatson C, Snell-Bergeon JK. Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar(®) in Type 1 Diabetes Management. Diabetes Ther. 2017 Aug;8(4):811-819. PubMed PMID: 28555339
• Garg SK, Akturk HK. Flash Glucose Monitoring: The Future Is Here. Diabetes Technol Ther. 2017 May;19(S2):S1-S3. PubMed PMID: 28541133
• Akturk HK, Nippoldt TB. Implications and Interpretations of Differences in Age-Adjusted Testosterone Levels-Reply. JAMA Intern Med. 2017 May 1;177(5):744. PubMed PMID: 28460107
• Akturk HK, Sotello D, Ameri A, Abuzaid AS, Rivas AM, Vashisht P. Toxoplasma Infection in an Immunocompetent Host: Possible Risk of Living with Multiple Cats. Cureus. 2017 Mar 19;9(3):e1103. PubMed PMID: 28435763
• Akturk HK, Smallridge R, Casler J. Rapidly Enlarging Thyroid Mass in a Patient With History of Multiple Cancers. JAMA Oncol. 2017 Jun 1;3(6):853-854. PubMed PMID: 28253395
• Akturk HK, Nippoldt TB. Low Testosterone in Men Should Be a Sign Rather Than a Number to Increase: A Teachable Moment. JAMA Intern Med. 2016 Dec 1;176(12):1743-1744. PubMed PMID: 27723882
• Oktay AA, Akturk HK, Jahangir E. Diabetes mellitus and hypertension: a dual threat. Curr Opin Cardiol. 2016 Jul;31(4):402-9. PubMed PMID: 27070651
• Garg S. Rewers A. Akturk HK. New Medications for the Treatment of Diabetes. ATTD Annual Book
• Akturk HK, Yasa S. Previously unreported abnormalities in Wolfram Syndrome Type 2. Pediatr Endocrinol Diabetes Metab. 2017;23(2):107-110. PubMed PMID: 29073294
• Akturk HK, Shah VN. Severe Hypoglycemia in Adults With Type 1 Diabetes After Switching to Insulin Degludec. J Diabetes Sci Technol. 2017 Nov 1;:1932296817742922. [Epub ahead of print] PubMed PMID: 29183157
• Akturk HK, Taylor DD, Camsari UM, Rewers A, Kinney GL, Shah VN. Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes. JAMA Intern Med. 2018 Nov 5. [Epub ahead of print] PubMed PMID: 30398521
• Akturk HK, Snell-Bergeon JK, Rewers A, Klaff LJ, Bode BW, Peters AL, Bailey TS, Garg SK. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. Diabetes Technol Ther. 2018 Oct;20(10):639-647. PubMed PMID: 30207748
• Akturk HK, Alkanani A, Zhao Z, Yu L, Michels AW. PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3589-3592. PubMed PMID: 30124874
• Prete A, Yan Q, Al-Tarrah K, Akturk HK, Prokop LJ, Alahdab F, Foster MA, Lord JM, Karavitaki N, Wass JA, Murad MH, Arlt W, Bancos I. The cortisol stress response induced by surgery: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018 Nov;89(5):554-567. PubMed PMID: 30047158
• Akturk HK, Rewers A, Joseph H, Schneider N, Garg SK. Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes. Diabetes Technol Ther. 2018 Jun;20(S2):S224-S232. PubMed PMID: 29916737
• Garg SK, Akturk HK. A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices. Diabetes Technol Ther. 2018 Jun;20(6):391-394. PubMed PMID: 29901411
• Garg SK, Rewers AH, Akturk HK. Ever-Increasing Insulin-Requiring Patients Globally. Diabetes Technol Ther. 2018 Jun;20(S2):S21-S24. PubMed PMID: 29873518
• Akturk HK, Rewers A, Garg SK. SGLT inhibition: a possible adjunctive treatment for type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):246-250. PubMed PMID: 29794497
• Zaied AA, Akturk HK, Joseph RW, Lee AS. New-onset insulin-dependent diabetes due to nivolumab. Endocrinol Diabetes Metab Case Rep. 2018;2018. PubMed PMID: 29623210
• Akturk HK, Michels AW. Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018 Mar 22;378(12):1163-4. PubMed PMID: 29565519
• Akturk HK. Management of Type 1 diabetes should be different from Type 2 diabetes at hospital admission. Diabet Med. 2018 Jun;35(6):824. PubMed PMID: 29505160
• Akturk HK, Chindris AM, Hines JM, Singh RJ, Bernet VJ. Over-the-Counter "Adrenal Support" Supplements Contain Thyroid and Steroid-Based Adrenal Hormones. Mayo Clin Proc. 2018 Mar;93(3):284-290. PubMed PMID: 29502560
• Oktay AA, Akturk HK, Esenboga K, Javed F, Polin NM, Jahangir E. Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus. Curr Probl Cardiol. 2018 Mar;43(3):68-110. PubMed PMID: 29471918
• Garg SK, Rewers AH, Akturk HK. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2018 Feb;20(S1):S139-S153. PubMed PMID: 29437472
• Akturk HK, Shah VN. Severe Hypoglycemia in Adults With Type 1 Diabetes After Switching to Insulin Degludec. J Diabetes Sci Technol. 2018 May;12(3):733-734. PubMed PMID: 29183157
• Barnard-Kelly KD, Naranjo D, Majidi S, Akturk HK, Breton M, Courtet P, Olié E, Lal RA, Johnson N, Renard E. Suicide and Self-inflicted Injury in Diabetes: A Balancing Act. J Diabetes Sci Technol. 2019 Dec 4;:1932296819891136. [Epub ahead of print] PubMed PMID: 31801353
• Akturk HK, Giordano D, Champakanath A, Brackett S, Garg S, Snell-Bergeon J. Long-term Real-life Glycemic Outcomes with Hybrid Closed-Loop System when Compared with Sensor-Augmented Pump Therapy in Patients with Type 1 Diabetes. Diabetes Obes Metab. 2019 Dec 2. [Epub ahead of print] PubMed PMID: 31789447
• Polsky S, Akturk HK. Case series of a hybrid closed-loop system used in pregnancies in clinical practice. Diabetes Metab Res Rev. 2019 Nov 22;:e3248. [Epub ahead of print] PubMed PMID: 31758630
• Kinney GL, Akturk HK, Taylor DD, Foster NC, Shah VN. Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry. Diabetes Care. 2019 Oct 18. [Epub ahead of print] PubMed PMID: 31628116
• Kaur H, Schneider N, Pyle L, Campbell K, Akturk HK, Shah VN. Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis. Diabetes Technol Ther. 2019 Dec;21(12):736-739. PubMed PMID: 31347928
• Akturk HK, Kahramangil D, Sarwal A, Hoffecker L, Murad MH, Michels AW. Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis. Diabet Med. 2019 Sep;36(9):1075-1081. PubMed PMID: 31199005
• Akturk HK, Michels AW. Adverse Events Associated With Immune Checkpoint Inhibitors. JAMA. 2019 Mar 26;321(12):1219. PubMed PMID: 30912828
• Akturk HK, Garg S. Technological advances shaping diabetes care. Curr Opin Endocrinol Diabetes Obes. 2019 Apr;26(2):84-89. PubMed PMID: 30720477
• Akturk HK, Taylor DD, Camsari UM, Rewers A, Kinney GL, Shah VN. Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes. JAMA Intern Med. 2019 Jan 1;179(1):115-118. PubMed PMID: 30398521
• Akturk HK, Michels AW. Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk. Mayo Clin Proc. 2020 Mar;95(3):614-615. PubMed PMID: 32138890
• Akturk HK, Michels AW. Adverse events associated with immune checkpoint inhibitors: a new era in autoimmune diabetes. Curr Opin Endocrinol Diabetes Obes. 2020 Aug;27(4):187-193. PubMed PMID: 32618630
• Oktay AA, Aktürk HK, Paul TK, O’Keefe JH, Ventura HO, Koch CA, Lavie CJ. Diabetes, Cardiomyopathy, and Heart Failure. . 2000. PubMed PMID: 32776639
• Akturk HK, Snell-Bergeon JK, Shah VN. Continuous Glucose Monitor with Siri Integration Improves Glycemic Control in Legally Blind Patients with Diabetes. Diabetes Technol Ther. 2020 Jul 30. [Epub ahead of print] PubMed PMID: 32758007
• Akturk HK, Michels AW. Adverse events associated with immune checkpoint inhibitors: a new era in autoimmune diabetes. Curr Opin Endocrinol Diabetes Obes. 2020 Aug;27(4):187-193. PubMed PMID: 32618630
• Akturk HK, Vigers T, Forlenza GP, Champakanath A, Pyle L. Comparison of cgmanalysis, a free, open-source continuous glucose monitoring (CGM) data management and analysis software to commercially available CGM platforms: Data standardization for diabetes technology research. Diabetes Technol Ther. 2021 Sep 15. [Epub ahead of print] PubMed PMID: 34524001
• Barnard-Kelly KD, Naranjo D, Majidi S, Akturk HK, Breton M, Courtet P, Olié E, Lal RA, Johnson N, Atkinson M, Renard E. An Intolerable Burden: Suicide, Intended Self-Injury and Diabetes. Can J Diabetes. 2020 Aug;44(6):541-544. PubMed PMID: 32305294
• Garg SK, Liljenquist D, Bode B, Christiansen MP, Bailey TS, Brazg RL, Denham DS, Chang AR, Akturk HK, Dehennis A, Tweden KS, Kaufman FR. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technol Ther. 2021 Sep 9. [Epub ahead of print] PubMed PMID: 34515521
• Akturk HK, Snell-Bergeon J, Pyle L, Fivekiller E, Garg S, Cobry E. Accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. J Diabetes Complications. 2021 Nov;35(11):108030. PubMed PMID: 34481712
• Akturk HK, Michels AW. Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk. Mayo Clin Proc. 2020 Mar;95(3):614-615. PubMed PMID: 32138890
• Akturk HK, Brackett S. A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors. Diabetes Technol Ther. 2020 Jul;22(7):538-540. PubMed PMID: 32031415
• Barnard-Kelly KD, Naranjo D, Majidi S, Akturk HK, Breton M, Courtet P, Olié E, Lal RA, Johnson N, Renard E. Suicide and Self-inflicted Injury in Diabetes: A Balancing Act. J Diabetes Sci Technol. 2020 Nov;14(6):1010-1016. PubMed PMID: 31801353
• Akturk HK, Shah VN. Gastric Emptying Abnormalities in Diabetes Mellitus. N Engl J Med. 2021 Aug 5;385(6):575-576. PubMed PMID: 34347967
• Shah VN, Akturk HK, Joseph H, Schneider N, Snell-Bergeon JK. A randomized controlled trial of transition from insulin pump to multiple daily injections using insulin degludec. Diabetes Obes Metab. 2021 Aug;23(8):1936-1941. PubMed PMID: 34180122
• Akturk HK, Agarwal S, Hoffecker L, Shah VN. Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards. Diabetes Care. 2021 Jun;44(6):e121-e123. PubMed PMID: 34016613
• Berget C, Akturk HK, Messer LH, Vigers T, Pyle L, Snell-Bergeon J, Driscoll KA, Forlenza GP. Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab. 2021 Sep;23(9):2048-2057. PubMed PMID: 34010499
• Akturk HK. Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light. Obstet Gynecol. 2021 Mar 1;137(3):443-444. PubMed PMID: 33543901
• Akturk HK, Giordano D, Champakanath A, Brackett S, Garg S, Snell-Bergeon J. Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes. Diabetes Obes Metab. 2020 Apr;22(4):583-589. PubMed PMID: 31789447
• Oktay AA, Aktürk HK, Paul TK, O’Keefe JH, Ventura HO, Koch CA, Lavie CJ. Diabetes, Cardiomyopathy, and Heart Failure. . 2000. PubMed PMID: 32776639
• Polsky S, Akturk HK. Case series of a hybrid closed-loop system used in pregnancies in clinical practice. Diabetes Metab Res Rev. 2020 Mar;36(3):e3248. PubMed PMID: 31758630
• Kinney GL, Akturk HK, Taylor DD, Foster NC, Shah VN. Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry. Diabetes Care. 2020 Jan;43(1):247-249. PubMed PMID: 31628116
• Acciaroli G, Welsh JB, Akturk HK. Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts. J Diabetes Sci Technol. 2021 Jan 5;:1932296820982584. [Epub ahead of print] PubMed PMID: 33401946
• Akturk HK, Dowd R, Shankar K, Derdzinski M. Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features. Diabetes Technol Ther. 2021 Mar;23(S1):S21-S26. PubMed PMID: 33434439
• Akturk HK, Snell-Bergeon JK, Shah VN. Continuous Glucose Monitor with Siri Integration Improves Glycemic Control in Legally Blind Patients with Diabetes. Diabetes Technol Ther. 2021 Jan;23(1):81-83. PubMed PMID: 32758007
• Akturk HK, Michels AW. Adverse events associated with immune checkpoint inhibitors: a new era in autoimmune diabetes. Curr Opin Endocrinol Diabetes Obes. 2020 Aug;27(4):187-193. PubMed PMID: 32618630
• Barnard-Kelly KD, Naranjo D, Majidi S, Akturk HK, Breton M, Courtet P, Olié E, Lal RA, Johnson N, Atkinson M, Renard E. An Intolerable Burden: Suicide, Intended Self-Injury and Diabetes. Can J Diabetes. 2020 Aug;44(6):541-544. PubMed PMID: 32305294
• Akturk HK, Michels AW. Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk. Mayo Clin Proc. 2020 Mar;95(3):614-615. PubMed PMID: 32138890
• Akturk HK, Brackett S. A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors. Diabetes Technol Ther. 2020 Jul;22(7):538-540. PubMed PMID: 32031415
• Polsky S, Akturk HK. Case series of a hybrid closed-loop system used in pregnancies in clinical practice. Diabetes Metab Res Rev. 2020 Mar;36(3):e3248. PubMed PMID: 31758630
• Akturk HK, Giordano D, Champakanath A, Brackett S, Garg S, Snell-Bergeon J. Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes. Diabetes Obes Metab. 2020 Apr;22(4):583-589. PubMed PMID: 31789447
• Barnard-Kelly KD, Naranjo D, Majidi S, Akturk HK, Breton M, Courtet P, Olié E, Lal RA, Johnson N, Renard E. Suicide and Self-inflicted Injury in Diabetes: A Balancing Act. J Diabetes Sci Technol. 2020 Nov;14(6):1010-1016. PubMed PMID: 31801353
• Kinney GL, Akturk HK, Taylor DD, Foster NC, Shah VN. Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry. Diabetes Care. 2020 Jan;43(1):247-249. PubMed PMID: 31628116
• Differentiating diabetic ketoacidosis and hyperglycemic ketosis due to cannabis hyperemesis syndrome in adults with type 1 diabetes
• Early diabetes technology adaption improves glycemic control-7 year follow up study
• Shah VN, Akturk HK, Vigers T, Pyle L, Oliver N, Klonoff DC. Relationship between daytime vs nighttime continuous glucose monitoring metrics with A1C in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 Oct 28. [Epub ahead of print] PubMed PMID: 36306519
• Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2022 Oct;28(10):2092-2099. PubMed PMID: 36192552
• Xu NY, Nguyen KT, Krouwer JS, Akturk HK, Shah VN, Klonoff DC. Retained Diabetes Devices-A Literature Review. J Diabetes Sci Technol. 2022 Jul 5;:19322968221105895. [Epub ahead of print] PubMed PMID: 35787699
• Akturk HK, Snell-Bergeon J, Shah VN. Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes. Diabetes Technol Ther. 2022 Oct;24(10):779-783. PubMed PMID: 35714344
• Akturk HK, Snell-Bergeon J, Shah VN. Health Care Professionals' Perspectives on Use of Diabetes Technologies for Managing Visually Impaired Patients With Diabetes. J Diabetes Sci Technol. 2022 Jun 4;:19322968221101629. [Epub ahead of print] PubMed PMID: 35658590
• Akturk HK, Herrero P, Oliver N, Wise H, Eikermann E, Snell-Bergeon J, Shah VN. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration. Diabetes Technol Ther. 2022 Oct;24(10):749-753. PubMed PMID: 35653736
• Ebekozien O, Mungmode A, Sanchez J, Rompicherla S, Demeterco-Berggren C, Weinstock RS, Jacobsen LM, Davis G, McKee A, Akturk HK, Maahs DM, Kamboj MK. Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative. Diabetes Technol Ther. 2023 Nov;25(11):765-773. PubMed PMID: 37768677
• Akturk HK, Sakamoto C, Vigers T, Shah VN, Pyle L. Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use. J Diabetes Sci Technol. 2023 Sep 25;:19322968231200901. [Epub ahead of print] PubMed PMID: 37747124
• Xu NY, Nguyen KT, DuBord AY, Pickup J, Sherr JL, Teymourian H, Cengiz E, Ginsberg BH, Cobelli C, Ahn D, Bellazzi R, Bequette BW, Gandrud Pickett L, Parks L, Spanakis EK, Masharani U, Akturk HK, Melish JS, Kim S, Kang GE, Klonoff DC. Diabetes Technology Meeting 2021. J Diabetes Sci Technol. 2022 Jul;16(4):1016-1056. PubMed PMID: 35499170
• Conway RB, Gerard Gonzalez A, Shah VN, Geno Rasmussen C, Akturk HK, Pyle L, Forlenza G, Alonso GT, Snell-Bergeon J. Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis. Diabetes Metab Syndr Obes. 2023;16:2295-2310. PubMed PMID: 37551339
• Garg SK, Kipnes M, Castorino K, Bailey TS, Akturk HK, Welsh JB, Christiansen MP, Balo AK, Brown SA, Reid JL, Beck SE. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther. 2022 Jun;24(6):373-380. PubMed PMID: 35157505
• Karakus KE, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade. Diabetes Care. 2023 Sep 1;46(9):1646-1651. PubMed PMID: 37458618
• Messer LH, Vigers T, Akturk HK, Forlenza GP, Huss KB, Karami AJ, Malecha E, Oser SM, Polsky S, Pyle L, Shah VN, Wadwa RP, Oser TK. Increasing Use of Diabetes Devices: What Do Health Care Professionals Need?. Clin Diabetes. 2023 Summer;41(3):386-398. PubMed PMID: 37456091
• Akturk HK, Snell-Bergeon J, Karakus KE, Shah VN. Assessing the relationship between low-calorie sweetener use and quality of life measures in adults with type 1 diabetes. BMC Endocr Disord. 2023 Jul 11;23(1):147. PubMed PMID: 37430302
• Elshimy G, Raj R, Akturk HK, Schriber A, Sisterna N, Ahmad I, Jacob A, Michels AW, Correa R. Immune Checkpoint Inhibitors Related Endocrine Adverse Events. . 2000. PubMed PMID: 35129941
• Karakus KE, Shah VN, Klonoff D, Akturk HK. Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes. Diabetes Obes Metab. 2023 Nov;25(11):3144-3151. PubMed PMID: 37427768
• Champakanath A, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study. Diabetes Care. 2022 Mar 1;45(3):750-753. PubMed PMID: 35018417
• Akturk HK, Snell-Bergeon J, Kinney GL, Champakanath A, Monte A, Shah VN. Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes. Diabetes Care. 2022 Feb 1;45(2):481-483. PubMed PMID: 34880067
• Akturk HK, Vigers T, Forlenza G, Champakanath A, Pyle L. Comparison of Cgmanalysis, a Free Open-Source Continuous Glucose Monitoring Data Management and Analysis Software, with Commercially Available CGM Platforms: Data Standardization for Diabetes Technology Research. Diabetes Technol Ther. 2022 Jan;24(1):54-60. PubMed PMID: 34524001
• Garg SK, Liljenquist D, Bode B, Christiansen MP, Bailey TS, Brazg RL, Denham DS, Chang AR, Akturk HK, Dehennis A, Tweden KS, Kaufman FR. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technol Ther. 2022 Feb;24(2):84-92. PubMed PMID: 34515521
• Acciaroli G, Welsh JB, Akturk HK. Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts. J Diabetes Sci Technol. 2022 May;16(3):677-682. PubMed PMID: 33401946
• Peter ME, Rioles N, Liu J, Chapman K, Wolf WA, Nguyen H, Basina M, Akturk HK, Ebekozien O, Perez-Nieves M, Poon JL, Mitchell B. Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician's perspective on its implementation. BMJ Open Diabetes Res Care. 2023 Jul;11(4). PubMed PMID: 37423638
• Alonso GT, Triolo TM, Akturk HK, Pauley ME, Sobczak M, Forlenza GP, Sakamoto C, Pyle L, Frohnert BI. Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes Care. 2023 Jun 1;46(6):1218-1222. PubMed PMID: 37023293
• Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2023 Mar 17. [Epub ahead of print] PubMed PMID: 36932248
• Mungmode A, Noor N, Weinstock RS, Izquierdo R, Indyk JA, DeSalvo DJ, Corathers S, Demeterco-Berggen C, Hsieh S, Jacobsen LM, Mekhoubad A, Akturk HK, Wirsch A, Scott ML, Chao LC, Miyazaki B, Malik FS, Ebekozien O, Clements M, Alonso GT. Making Diabetes Electronic Medical Record Data Actionable: Promoting Benchmarking and Population Health Improvement Using the T1D Exchange Quality Improvement Portal. Clin Diabetes. 2022 Winter;41(1):45-55. PubMed PMID: 36714251
• Akturk HK, Rompicherla S, Rioles N, Desimone M, Weinstock RS, Haw SJ, Ziemer DC, Dickinson JK, Agarwal S, Ebekozien O, Polsky S. Factors Associated With Improved A1C Among Adults With Type 1 Diabetes in the United States. Clin Diabetes. 2022 Winter;41(1):76-80. PubMed PMID: 36714244
• Shah VN, Kanapka LG, Akturk HK, Polsky S, Forlenza GP, Kollman C, Beck RW, Snell-Bergeon JK. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes Technol Ther. 2024 Apr;26(4):246-251. PubMed PMID: 38133643
• Akturk HK, McKee AM. Emerging Technologies and Therapeutics for Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar;53(1):81-91. PubMed PMID: 38272600
• Akturk HK, Battelino T, Castañeda J, Arrieta A, van den Heuvel T, Cohen O. Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes Technol Ther. 2024 Mar;26(S3):102-106. PubMed PMID: 38377325
• Akturk HK, Michel K, Couts K, Karakus KE, Robinson W, Michels A. Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes Care. 2024 Mar 1;47(3):e29-e30. PubMed PMID: 38232313
• Gandhi K, Ebekozien O, Noor N, McDonough RJ, Hsieh S, Miyazaki B, Dei-Tutu S, Golden L, Desimone M, Hardison H, Rompicherla S, Akturk HK, Kamboj MK. Insulin Pump Utilization in 2017-2021 for More Than 22,000 Children and Adults With Type 1 Diabetes: A Multicenter Observational Study. Clin Diabetes. 2024 Winter;42(1):56-64. PubMed PMID: 38230341
• Karakus KE, Mason E, Akturk HK. Long-term glycaemic improvement with the initiation of an automated insulin delivery system in insulin pump-naïve older adults with type 1 diabetes. Diabetes Obes Metab. 2024 Oct 7. [Epub ahead of print] PubMed PMID: 39375861
• Klonoff DC, Freckmann G, Pleus S, Kovatchev BP, Kerr D, Tse CC, Li C, Agus MSD, Dungan K, Voglová Hagerf B, Krouwer JS, Lee WA, Misra S, Rhee SY, Sabharwal A, Seley JJ, Shah VN, Tran NK, Waki K, Worth C, Tian T, Aaron RE, Rutledge K, Ho CN, Ayers AT, Adler A, Ahn DT, Aktürk HK, Al-Sofiani ME, Bailey TS, Baker M, Bally L, Bannuru RR, Bauer EM, Bee YM, Blanchette JE, Cengiz E, Chase JG, Y Chen K, Cherñavvsky D, Clements M, Cote GL, Dhatariya KK, Drincic A, Ejskjaer N, Espinoza J, Fabris C, Fleming GA, Gabbay MAL, Galindo RJ, Gómez-Medina AM, Heinemann L, Hermanns N, Hoang T, Hussain S, Jacobs PG, Jendle J, Joshi SR, Koliwad SK, Lal RA, Leiter LA, Lind M, Mader JK, Maran A, Masharani U, Mathioudakis N, McShane M, Mehta C, Moon SJ, Nichols JH, O'Neal DN, Pasquel FJ, Peters AL, Pfützner A, Pop-Busui R, Ranjitkar P, Rhee CM, Sacks DB, Schmidt S, Schwaighofer SM, Sheng B, Simonson GD, Sode K, Spanakis EK, Spartano NL, Umpierrez GE, Vareth M, Vesper HW, Wang J, Wright E, Wu AHB, Yeshiwas S, Zilbermint M, Kohn MA. The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors. J Diabetes Sci Technol. 2024 Oct 6;:19322968241275701. [Epub ahead of print] PubMed PMID: 39369312
• Akturk HK, Bindal A. Advances in diabetes technology within the digital diabetes ecosystem. J Manag Care Spec Pharm. 2024 Oct;30(10-b Suppl):S7-S20. PubMed PMID: 39347970
• Karakus KE, Shah VN, Akturk HK. Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis. JAMA Intern Med. 2024 Oct 1;184(10):1246-1247. PubMed PMID: 39102259
• Hirsch IB, Beck RW, Marak MC, Calhoun P, Mottalib A, Salhin A, Manessis A, Coviello AD, Bhargava A, Thorsell A, Atakov Castillo A, Bode BW, Levister C, Levy CJ, Donahue C, Cordero C, Beatson C, Langel CR, Jacobson C, Kurek C, Cruse D, Pickering D, Tamarez D, Steenkamp DW, Desjardins D, Aleppo G, O'Malley G, Akturk HK, Diner J, Baran JD, Buse JB, Ruedy K, Codorniz K, Klein KR, Castorino K, Jordan LF, Kipnes M, Church MM, Hamdy O, Raskin P, Nguyen QT, Weinstock RS, Lee S, Rizvi S, Bzdick S, Ghorbani Rodriguez T, Salah T, Blevins T, Kudva YC, Haider Z. A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes Care. 2024 Sep 1;47(9):1682-1687. PubMed PMID: 39042575
• Akturk HK. Access to Diabetes Care Should Be a Universal Right for People With Type 1 Diabetes: Lessons Learned From the Norwegian Childhood Diabetes Registry. Diabetes Care. 2024 Jul 1;47(7):1111-1113. PubMed PMID: 38900950
• Karakus KE, Klein MP, Akturk HK, Shah VN. Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ. Diabetes Ther. 2024 Jul;15(7):1647-1655. PubMed PMID: 38743306
• Akturk HK. Recent Advances in Diabetes Technology and Activities of the American Diabetes Association Diabetes Technology Interest Group. Clin Diabetes. 2024 Spring;42(2):316-321. PubMed PMID: 38694248
• Klein MP, Akturk HK, Snell-Bergeon JK, Shah VN. Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity. J Diabetes Sci Technol. 2024 Apr 17;:19322968241245680. [Epub ahead of print] PubMed PMID: 38629877
• Tian T, Aaron RE, DuNova AY, Jendle JH, Kerr D, Cengiz E, Drincic A, Pickup JC, Chen KY, Schwartz N, Muchmore DB, Akturk HK, Levy CJ, Schmidt S, Bellazzi R, Wu AHB, Spanakis EK, Najafi B, Chase JG, Seley JJ, Klonoff DC. Diabetes Technology Meeting 2023. J Diabetes Sci Technol. 2024 Sep;18(5):1208-1244. PubMed PMID: 38528741
• Garg SK, Akturk HK, Kaur G, Beatson C, Snell-Bergeon J. Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes. Diabetes Technol Ther. 2024 Jun;26(6):367-374. PubMed PMID: 38512447
• Carlson AL, Graham TE, Akturk HK, Liljenquist DR, Bergenstal RM, Sulik B, Shah VN, Sulik M, Zhao P, Briggs P, Sassan-Katchalski R, Pinsker JE. Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial. J Diabetes Sci Technol. 2024 Mar 5;:19322968241234072. [Epub ahead of print] PubMed PMID: 38439656
• Akturk HK, Battelino T, Castañeda J, Arrieta A, van den Heuvel T, Cohen O. Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes Technol Ther. 2024 Mar;26(S3):102-106. PubMed PMID: 38377325
• Shah VN, Akturk HK, Trahan A, Piquette N, Wheatcroft A, Schertz E, Carmello K, Mueller L, White K, Fu L, Sassan-Katchalski R, Messer LH, Habif S, Constantin A, Pinsker JE. Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology. J Diabetes Sci Technol. 2024 Feb 7;:19322968241229074. [Epub ahead of print] PubMed PMID: 38323362
• Akturk HK, Dong F, Snell-Bergeon JK, Karakus KE, Shah VN. Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study. J Diabetes Sci Technol. 2024 Feb 5;:19322968231223991. [Epub ahead of print] PubMed PMID: 38317405
• Akturk HK. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes. Diabetes Technol Ther. 2024 Jul;26(7):503-508. PubMed PMID: 38300516
• Akturk HK, McKee AM. Emerging Technologies and Therapeutics for Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar;53(1):81-91. PubMed PMID: 38272600
• Akturk HK, Michel K, Couts K, Karakus KE, Robinson W, Michels A. Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes Care. 2024 Mar 1;47(3):e29-e30. PubMed PMID: 38232313
• Gandhi K, Ebekozien O, Noor N, McDonough RJ, Hsieh S, Miyazaki B, Dei-Tutu S, Golden L, Desimone M, Hardison H, Rompicherla S, Akturk HK, Kamboj MK. Insulin Pump Utilization in 2017-2021 for More Than 22,000 Children and Adults With Type 1 Diabetes: A Multicenter Observational Study. Clin Diabetes. 2024 Winter;42(1):56-64. PubMed PMID: 38230341
• Shah VN, Kanapka LG, Akturk HK, Polsky S, Forlenza GP, Kollman C, Beck RW, Snell-Bergeon JK. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes Technol Ther. 2024 Apr;26(4):246-251. PubMed PMID: 38133643
• Ebekozien O, Mungmode A, Sanchez J, Rompicherla S, Demeterco-Berggren C, Weinstock RS, Jacobsen LM, Davis G, McKee A, Akturk HK, Maahs DM, Kamboj MK. Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative. Diabetes Technol Ther. 2023 Nov;25(11):765-773. PubMed PMID: 37768677
• Akturk HK, Sakamoto C, Vigers T, Shah VN, Pyle L. Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use. J Diabetes Sci Technol. 2023 Sep 25;:19322968231200901. [Epub ahead of print] PubMed PMID: 37747124
• Conway RB, Gerard Gonzalez A, Shah VN, Geno Rasmussen C, Akturk HK, Pyle L, Forlenza G, Alonso GT, Snell-Bergeon J. Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis. Diabetes Metab Syndr Obes. 2023;16:2295-2310. PubMed PMID: 37551339
• Karakus KE, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade. Diabetes Care. 2023 Sep 1;46(9):1646-1651. PubMed PMID: 37458618
• Messer LH, Vigers T, Akturk HK, Forlenza GP, Huss KB, Karami AJ, Malecha E, Oser SM, Polsky S, Pyle L, Shah VN, Wadwa RP, Oser TK. Increasing Use of Diabetes Devices: What Do Health Care Professionals Need?. Clin Diabetes. 2023 Summer;41(3):386-398. PubMed PMID: 37456091
• Akturk HK, Snell-Bergeon J, Karakus KE, Shah VN. Assessing the relationship between low-calorie sweetener use and quality of life measures in adults with type 1 diabetes. BMC Endocr Disord. 2023 Jul 11;23(1):147. PubMed PMID: 37430302
• Karakus KE, Shah VN, Klonoff D, Akturk HK. Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes. Diabetes Obes Metab. 2023 Nov;25(11):3144-3151. PubMed PMID: 37427768
• Peter ME, Rioles N, Liu J, Chapman K, Wolf WA, Nguyen H, Basina M, Akturk HK, Ebekozien O, Perez-Nieves M, Poon JL, Mitchell B. Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician's perspective on its implementation. BMJ Open Diabetes Res Care. 2023 Jul;11(4). PubMed PMID: 37423638
• Alonso GT, Triolo TM, Akturk HK, Pauley ME, Sobczak M, Forlenza GP, Sakamoto C, Pyle L, Frohnert BI. Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes Care. 2023 Jun 1;46(6):1218-1222. PubMed PMID: 37023293
• Shah VN, Akturk HK, Vigers T, Pyle L, Oliver N, Klonoff DC. Relationship Between Daytime Versus Nighttime Continuous Glucose Monitoring Metrics with A1C in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2023 Jan;25(1):62-68. PubMed PMID: 36306519
• Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2023 Nov;29(11):2959. PubMed PMID: 36932248
• Xu NY, Nguyen KT, Krouwer JS, Akturk HK, Shah VN, Klonoff DC. Retained Diabetes Devices-A Literature Review. J Diabetes Sci Technol. 2023 Nov;17(6):1676-1685. PubMed PMID: 35787699
• Akturk HK, Snell-Bergeon J, Shah VN. Health Care Professionals' Perspectives on Use of Diabetes Technologies for Managing Visually Impaired Patients With Diabetes. J Diabetes Sci Technol. 2023 Nov;17(6):1610-1613. PubMed PMID: 35658590

Practice Locations

• University of Colorado Hospital

• Barbara Davis Center for Childhood Diabetes

Specialty Information

• Endocrinology, Diabetes and Metabolism, Board Certification
• Internal Medicine, Board Certification (2014)

• Endocrine System (Hormones) - Adult Type 1 Diabetes
• Endocrine System (Hormones)
• Endocrine System (Hormones) - Adult Type 2 Diabetes